A small case study on the safety of the abortion pill reversal procedure that was cut short due to safety concerns does not accurately represent the safety and efficacy of the procedure to the public, a pro-life group has said.
“Pro-abortion researchers would rather continue to mislead women about the real risks of the abortion pill regimen Mifeprex than protect them from the risks of this dangerous drug,” Dr. Tara Sander Lee, senior fellow, and director of life sciences for the Charlotte Lozier Institute said in a statement.
Earlier this year, a group of researchers from the University of California at Davis attempted to study whether administering high doses of the hormone progesterone can successfully override the effects of the progesterone-blocking drug, mifepristone, the first of two pills taken in a medically induced abortion. The second drug, misoprostol, is taken up to two days later and induces labor.
This abortion pill reversal procedure is administered to women who have taken the first pill, mifepristone, but have changed their minds and do not want to continue with the abortion. Creators of the protocol say it has saved hundreds of babies whose mothers changed their minds about aborting.
According to an NPR report, while the researchers at UC Davis were hoping that 40 women would enroll in the study, only 12 did. Of those 12, three women were transported to the hospital for serious vaginal bleeding – one of those women had been given progesterone, the others had received a placebo. CNA
